Effect of Dietary Phytochemicals on Metabolic Syndrome and Neurological Disorders

  • Akhlaq A. Farooqui
Chapter

Abstract

The widespread prevalence and deleterious effects of MetS have become a major public health challenge as it is associated with the development of type II diabetes, cardiovascular diseases, and age-related neurological disorders. This situation is caused by the consumption of Western diet, which is enriched in saturated and n-6 fatty acids and cholesterol. These dietary components may be responsible for induction of insulin resistance and maintenance of oxidative stress, and inflammation. In contrast, the consumption of diet enriched in fruits (polyphenols), vegetables (fiber), dry fruits (n-3 fatty acids, proteins of plant origin), and whole grains sensitizes insulin and decreases oxidative stress and inflammation by lowering levels of ROS, AGEs, lipid mediators, and cytokines. Thus, lifestyle modifications involving changes in diet and exercise may produce promising effects in managing MetS, diabetes, cardiovascular disease risk, and neurological disorders.

Keywords

Cholesterol Dementia Schizophrenia Serotonin Neuropathy 

References

  1. Abdel-Kader R, Hauptmann S, Keil U, Scherping I, Leuner K, Eckert A, Müller WE (2007) Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761®). Pharmacol Res 56:493–502PubMedGoogle Scholar
  2. Adisakwattana S, Sompong W, Meeprom A, Ngamukote S, Yibchok-Anun S (2012) Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int J Mol Sci 13:1778–1789PubMedGoogle Scholar
  3. Aggarwal BB (2010) Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 30:173–199PubMedGoogle Scholar
  4. Agrawal R, Gomez-Pinilla F (2012) “Metabolic syndrome” in the brain: Deficiency in omega-3-fatty acid exacerbates dysfunctions in insulin receptor signaling and cognition. J Physiol 590:2485–2499PubMedGoogle Scholar
  5. Amagase H (2006) Clarifying the real bioactive constituents of garlic. J Nutr 136:716S–725SPubMedGoogle Scholar
  6. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K, Priyadarsini IK, Rajasekharan KN, Aggarwal BB (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76:1590–1611PubMedGoogle Scholar
  7. Anderson RA, Polansky MM (2002) Tea enhances insulin activity. J Agric Food Chem 50:7182–7186PubMedGoogle Scholar
  8. Anton S, Melville L, Rena G (2007) Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell Signal 19:378–383PubMedGoogle Scholar
  9. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F (2005) Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care 28:2823–2831PubMedGoogle Scholar
  10. Banerjee KS, Moulik SK (2000) Effect of garlic on cardiovascular disorders: a review. Nutri J 1:1–14Google Scholar
  11. Baran SE, Campbell AM, Kleen JK, Foltz CH, Wright RL, Diamond DM, Conrad CD (2005) Combination of high fat diet and chronic stress retracts hippocampal dendrites. Neuroreport 16:39–43PubMedGoogle Scholar
  12. Barros RP, Machado UF, Gustafsson JA (2006a) Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 12:425–431PubMedGoogle Scholar
  13. Barros RP, Machado UF, Warner M, Gustafsson JA (2006b) Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci USA 103:1605–1608PubMedGoogle Scholar
  14. Bas O, Songur A, Sahin O, Mollaoglu H, Ozen OA, Yaman M, Eser O, Fidan H, Yagmurca M (2007) The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 50:548–554PubMedGoogle Scholar
  15. Bastianetto S, Ramassamy C, Doré S, Christen Y, Poirier J, Quirion R (2000) The Ginkgo biloba extract (EGb 761®) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 12:1882–1891PubMedGoogle Scholar
  16. Bazan NG (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 15:159–166PubMedGoogle Scholar
  17. Bazan NG (2009) Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations and Alzheimer’s disease. J Lipid Res 50(Suppl):S400–405PubMedGoogle Scholar
  18. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA (2008) Curcumin structure function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther 326:196–208PubMedGoogle Scholar
  19. Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, Pi-Sunyer FX, Ballantyne CM, Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group (2009) Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 33:197–199Google Scholar
  20. Belayev L, Khoutorova L, Atkins KD, Eady TN, Hong S, Lu Y, Obenaus A, Bazan NG (2011) Docosahexaenoic acid therapy of experimental ischemic stroke. Transl Stroke Res 2:33–41PubMedGoogle Scholar
  21. Bent S, Ko R (2004) Commonly used herbal medicines in the United States: a review. Am J Med 116:478–485PubMedGoogle Scholar
  22. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP (2004) Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114:1741–51PubMedGoogle Scholar
  23. Bousquet M, Saint-Pierre M, Julien C, Salem N Jr, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J 22:1213–1225PubMedGoogle Scholar
  24. Breen DM, Sanli T, Giacca A, Tsiani E (2008) Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 374:117–122PubMedGoogle Scholar
  25. Broadhurst CL, Polansky MM, Anderson RA (2000) Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 48:849–852PubMedGoogle Scholar
  26. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, Bluck L, Coward A, Hendrickx H (2008) Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutri 101:886–894Google Scholar
  27. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625PubMedGoogle Scholar
  28. Bruckdorfer KR, Kang SS, Yudkin J (1973) Plasma concentrations of insulin, corticosterone, lipids and sugars in rats fed on meals with glucose and fructose. Proc Nutr Soc 32:12–13Google Scholar
  29. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011–2015PubMedGoogle Scholar
  30. Butterfield DA, Howard BJ, Yatin S, Allen KL, Carney JM (1997) Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci USA 94:674–78PubMedGoogle Scholar
  31. Cabrera C, Artacho R, Giménez R (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25:79–99PubMedGoogle Scholar
  32. Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, Cuzzocrea S, Rizzarelli E, Calabrese EJ (2012) Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta 1822:753–783Google Scholar
  33. Calon F, Lim GP, Yang FS, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem NJ, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron 43:633–645PubMedGoogle Scholar
  34. Cao H., Hininger-Favier I., Kelly M.A., Benaraba R., Dawson H.D., Coves S., Roussel A.M., and Anderson R.A. (2007a). Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J Agric Food Chem. 55:6372–6378PubMedGoogle Scholar
  35. Cao D., Yang B., Hou L., Xu J., Xue R., Sun L., Zhou C., and Liu Z. (2007b). Chronic daily administration of ethyl docosahexaenoate protects against gerbil brain ischemic damage through reduction of arachidonic acid liberation and accumulation. J. Nutr. Biochem. 18:297–304PubMedGoogle Scholar
  36. Cao H, Graves DJ, Anderson RA (2010) Cinnamon extract regulates glucose transporter and insulin-signaling gene expression in mouse adipocytes. Phytomedicine 17:1027–1032PubMedGoogle Scholar
  37. Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, De Caterina R (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23:622–629PubMedGoogle Scholar
  38. Chao J, Yu MS, Ho HS, Wang M, Chang RC (2006) Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Rad Biol Med 45:1019–1026Google Scholar
  39. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD (2002) Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155:732–738PubMedGoogle Scholar
  40. Chen PC, Wheeler DS, Malhotra V, Odoms K, Denenberg AG, Wong HR (2002) A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits I kappa B kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 26:233–241PubMedGoogle Scholar
  41. Cole GM, Ma QL, Frautschy SA (2009) Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids 81:213–221PubMedGoogle Scholar
  42. Colín-González A.L., Ortiz-Plata A., Villeda-Hernández J., Barrera D., Molina-Jijón E., Pedraza-Chaverrí J., and Maldonado P.D. (2011). Aged Garlic Extract Attenuates Cerebral Damage and Cyclooxygenase-2 Induction after Ischemia and Reperfusion in Rats. Plant Foods Hum Nutr 66:348–354Google Scholar
  43. Collins QF, Liu HY, Pi J, Liu Z, Quon MJ, Cao W (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. J Biol Chem 282:30143–30149PubMedGoogle Scholar
  44. Couturier K, Batandier C, Awada M, Hininger-Favier I, Canini F, Anderson RA, Leverve X, Roussel AM (2010) Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome. Arch Biochem Biophys 501:158–161PubMedGoogle Scholar
  45. Crawford P (2009) Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 22:507–512PubMedGoogle Scholar
  46. Dansen TB, Smits LM, van Triest MH, de Keizer PL, van Leenen D, Koerkamp MG, Szypowska A, Meppelink A, Brenkman AB, Yodoi J, Holstege FC, Burgering BM (2009) Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat Chem Biol 5:664–672PubMedGoogle Scholar
  47. Das S, Das DK (2007) Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 6:168–173PubMedGoogle Scholar
  48. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction. Testing and clinical relevance Circulation 115:1285–1295Google Scholar
  49. Delattre AM, Kiss A, Szawka RE, Anselmo-Franci JA, Bagatini PB, Xavier LL, Rigon P, Achaval M, Iagher F, de David C, Marroni NA, Ferraz AC (2010) Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson’s disease. Neurosci Res 66:256–264Google Scholar
  50. Demarin V, Lisak M, Morovic S (2011) Mediterranean diet in healthy lifestyle and prevention of stroke. Acta Clin Croat 50:67–77PubMedGoogle Scholar
  51. Deng J-Y, Hsieh P-S, Huang J-P, Lu L-S, Hung L-M (2008) Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 57:1814–1823PubMedGoogle Scholar
  52. Dias GP, Cavegn N, Nix A, do Nascimento Bevilaqua MC, Stangl D, Zainuddin MS, Nardi AE, Gardino PF, Thuret S (2012) The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety. Oxid Med Cell Longev 2012:541971PubMedGoogle Scholar
  53. Eckert A, Keil U, Kressmann S, Schindowski K, Leutner S, Leutz S, Müller WE (2003) Effects of EGb 761® Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 36(Suppl 1):S15–S23PubMedGoogle Scholar
  54. Ejaz A, Wu D, Kwan P, Meydani M (2009) Curcumin inhibits adipogenesis in 3 T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139:919–925PubMedGoogle Scholar
  55. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, Burgering BM (2004) FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23:4802–4812PubMedGoogle Scholar
  56. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599–622PubMedGoogle Scholar
  57. Farooqui AA (2009) Beneficial effects of fish oil human brain. Springer, New YorkGoogle Scholar
  58. Farooqui AA (2010) Neurochemical aspects of neurotraumatic and neurodegenerative diseases. Springer, New YorkGoogle Scholar
  59. Farooqui AA (2011) Lipid mediators and their metabolism in the brain. Springer, New YorkGoogle Scholar
  60. Farooqui AA (2012a) Generation of reactive oxygen species in the brain: signaling for neural cell survival or suicide. In: Farooqui T, Farooqui AA (eds) Oxidative stress in vertebrates and invertebrates. Wiley-Blackwell, Hoboken, NJ, pp 3–15Google Scholar
  61. Farooqui AA (2012b) Phytochemicals, signal transduction, and neurological disorders. Springer, New YorkGoogle Scholar
  62. Farooqui AA (2012c) n-3 Fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation. Curr Med Chem 19:532–543PubMedGoogle Scholar
  63. Farooqui T, Farooqui AA (2010) Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130:203–215Google Scholar
  64. Farooqui AA, Farooqui T (2011) Perspective and direction for future research on phytochemicals. In: Farooqui AA, Farooqui T (eds) Phytochemicals and human health: pharmacological and molecular aspects. Nova Science Publishers, Inc, New York, pp 501–513Google Scholar
  65. Farooqui AA, Horrocks LA (2007) Glycerophospholipids in the brain: phospholipases A2 in neurological disorders. Springer, New YorkGoogle Scholar
  66. Farooqui AA, Horrocks LA, Farooqui T (2007a) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577–599PubMedGoogle Scholar
  67. Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T (2007b) Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 56:443–471PubMedGoogle Scholar
  68. Farooqui AA, Farooqui T, Panza F, Frisardi V (2012) Metabolic syndrome as a risk factor for neurological disorders. Cell Mol Life Sci 69:741–762PubMedGoogle Scholar
  69. Fehske CJ, Leuner K, Müller WE (2009) Ginkgo biloba extract (EGb 761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol Res 60:68–73PubMedGoogle Scholar
  70. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63:1402–1408PubMedGoogle Scholar
  71. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M (2011) Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. PLoS One 6:e16564PubMedGoogle Scholar
  72. Garrel DR, Razi M, Lariviere F, Jobin N, Naman N, Emptoz-Bonneton A, Pugeat MM (1995) Improved clinical status and length of care with low-fat nutrition support in burn patients. J Parenter Enteral Nutr 19:482–491Google Scholar
  73. Gershwin ME, Borchers AT, Keen CL, Hendler S, Hagie F, Greenwood MR (2010) Public safety and dietary supplementation. Ann N Y Acad Sci 1190:104–117PubMedGoogle Scholar
  74. Ghosh S, Novak EM, Innis SM (2007) Cardiac proinflammatory pathways are altered with different dietary n-6 linoleic to n-3 α-linolenic acid ratios in normal, fat-fed pigs. Am J Physiol Heart Circ Physiol 293:H2919–H2927PubMedGoogle Scholar
  75. Giri RK, Selvaraj SK, Kalra VK (2003) Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol 170:5281–5294PubMedGoogle Scholar
  76. Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG (2010) Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58:2095–2099PubMedGoogle Scholar
  77. Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3A–11APubMedGoogle Scholar
  78. Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R (2004) Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141:997–1005PubMedGoogle Scholar
  79. Hashimoto M, Hossain S, Shimada T, Shido O (2006) Docosahexaenoic acid-induced protective effect against impaired learning in amyloid β-infused rats is associated with increased synaptosomal membrane fluidity. Clin Exp Pharmacol Physiol 33:934–939PubMedGoogle Scholar
  80. Hashimoto M, Shahdat HM, Yamashita S, Katakura M, Tanabe Y, Fujiwara H, Gamoh S, Miyazawa T, Arai H, Shimada T, Shido O (2008) Docosahexaenoic acid disrupts in vitro amyloid beta fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. J Neurochem 107:1634–1646PubMedGoogle Scholar
  81. He K, Rimm EB, Merchant A, Rosner BA, Stampfer MJ, Willett WC, Ascherio A (2002) Fish consumption and risk of stroke in men. JAMA 288:3130–3136PubMedGoogle Scholar
  82. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS (2000) Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci USA 97:12729–12734PubMedGoogle Scholar
  83. Henry LA, Witt DM (2002) Resveratrol: phytoestrogen effects on reproductive physiology and behavior in female rats. Horm Behav 41:220–228PubMedGoogle Scholar
  84. Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43:89–143PubMedGoogle Scholar
  85. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Yun YP, Lee BM, Kim PY (2001) Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res 888:11–18PubMedGoogle Scholar
  86. Hossain MS, Hashimoto M, Masumura S (1998) Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. Neurosci Lett 244:157–160PubMedGoogle Scholar
  87. Hossain MS, Hashimoto M, Gamoh S, Masumura S (1999) Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. J Neurochem 72:1133–1138PubMedGoogle Scholar
  88. Huynh NN, Chin-Dusting J (2006) Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol 33:1–8PubMedGoogle Scholar
  89. Iso H, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC (2001) Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285:304–312PubMedGoogle Scholar
  90. Jang JH, Surh YJ (2003) Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med 34:1100–1110PubMedGoogle Scholar
  91. Joseph JA, Shukitt-Hale B, Willis LM (2009) Grape juice, berries, and walnuts affect brain aging and behavior. J Nutr 139:1813S–1817SPubMedGoogle Scholar
  92. Kaplan S, Bisleri G, Morgan JA, Cheema FH, Oz MC (2005) Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg 80:2242–2249PubMedGoogle Scholar
  93. Kasper S, Schubert H (2009) Ginkgo-Spezialextrakt EGb 761® in der Behandlung der Demenz: Evidenz für Wirksamkeit und Verträglichkeit [Ginkgo biloba extract EGb 761® in the treatment of dementia: evidence of efficacy and tolerability]. Fortschr Neurol Psychiatr 77:494–506PubMedGoogle Scholar
  94. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26:3215–3218PubMedGoogle Scholar
  95. Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, Raza SS, Khan A, Javed H, Vaibhav K, Islam F (2010) Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res 1328:139–151PubMedGoogle Scholar
  96. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Pulgserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169–3179PubMedGoogle Scholar
  97. Kim J, Lee HJ, Lee KW (2010) Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem 112:1415–1430PubMedGoogle Scholar
  98. Kimura Y, Kimura H (2004) Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18:1165–1167PubMedGoogle Scholar
  99. King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, Michael-Titus AT (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26:4672–4680PubMedGoogle Scholar
  100. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, van Staveren WA (2004) Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292:1433–1439PubMedGoogle Scholar
  101. Koch HP, Lawson LD (1996) Garlic: the science and therapeutic application of Allium sativum L. and related species, 2nd edn. Williams & Wilkins, BaltimoreGoogle Scholar
  102. Koh SH, Kim SH, Kwon H, Kim JG, Kim JH, Yang KH, Kim J, Kim SU, Yu HJ, Do BR, Kim KS, Jung HK (2004) Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal differentiated N18D3 cells. Neurotoxicology 25:793–802PubMedGoogle Scholar
  103. Költringer P, Langsteger W, Eber O (1995) Dose-dependent hemorheological effects and microcirculatory modifications following intravenous administration of Ginkgo biloba special extract EGb 761®. Clin Hemorheol 15:649–656Google Scholar
  104. Kulkarni SK, Bhutani MK, Bishnoi M (2008) Antidepressant activity of curcumin: Involvement of serotonin and dopamine system. Psychopharmacology (Berl) 201:435–442Google Scholar
  105. Kulkarni S, Dhir A, Akula KK (2009) Potentials of curcumin as an antidepressant. ScientificWorld J 9:1233–1241Google Scholar
  106. Kuner P, Schubenel R, Hertel C (1998) Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. J Neurosci Res 54:798–804PubMedGoogle Scholar
  107. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109–1122PubMedGoogle Scholar
  108. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM (1997) Activation of the receptor foe advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810–14PubMedGoogle Scholar
  109. Lang-Lazdunski L, Biondeau N, Jarretou G, Heurteaux C (2003) Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J Vasc Surg 38:564–575PubMedGoogle Scholar
  110. Lankinen M, Schwab U, Kolehmainen M, Paananen J, Poutanen K, Mykkänen H, Seppänen-Laakso T, Gylling H, Uusitupa M, Orešič M (2011) Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study. PLoS One 6:e22646PubMedGoogle Scholar
  111. Lê KA, Tappy L (2006) Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 9(4):469–475PubMedGoogle Scholar
  112. Lee S, Suh S, Kim S (2000) Protective effects of the green tea polyphenol (−)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 287:191–194PubMedGoogle Scholar
  113. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S (2001) Green tea polyphenol (−)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78:1073–1082PubMedGoogle Scholar
  114. Levites Y, Amit T, Mandel S, Youdim MB (2003) Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (−)-epigallocatechin-3-gallate. FASEB J 17:952–954PubMedGoogle Scholar
  115. Li Z, Kaplan ML, Hatchey DL (2000) Hepatic microsomal and peroxisomal docosahexaenoate biosynthesis during piglet development. Lipids 35:1325–1333PubMedGoogle Scholar
  116. Li L, Braiteh FS, Kurzrock R (2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104:1322–1331PubMedGoogle Scholar
  117. Li C, Allen A, Kwagh J, Doliba NM, Qin W, Najafi H, Collins HW, Matschinsky FM, Stanley CA, Smith TJ (2006) Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem 281:10214–10221PubMedGoogle Scholar
  118. Liu A, Lou H, Zhao L, Fan P (2006) Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J Pharm Biomed Anal 40:720–727PubMedGoogle Scholar
  119. Liu C, Shi Z, Fan L, Zhang C, Wang K, Wang B (2011) Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 1374:100–109PubMedGoogle Scholar
  120. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115:2774–2783PubMedGoogle Scholar
  121. Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautschy SA, Cole GM (2009a) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078–9089PubMedGoogle Scholar
  122. Ma QL, Yang F, Rosario ER, Ubeda QJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautchy SA, Cole GM (2009b) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078–9089PubMedGoogle Scholar
  123. Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MB (2008) Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr 138:1578S–1583SPubMedGoogle Scholar
  124. Mattson MP, Cheng A (2006) Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 29:632–639PubMedGoogle Scholar
  125. Mattson MP, Son TG, Camandola S (2007) Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response 5:174–186PubMedGoogle Scholar
  126. Mattson MP (2008) Hormesis defined. Ageing Res Rev 7:1–7PubMedGoogle Scholar
  127. McEwen BS (2001) Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann NY Acad Sci 933:265–277PubMedGoogle Scholar
  128. Michael-Titus AT (2007) Omega-3 fatty acids and neurological injury. Prost Leukot Essent Fatty Acids 77:295–300Google Scholar
  129. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712–716PubMedGoogle Scholar
  130. Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F (2009) Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120:888–896PubMedGoogle Scholar
  131. Mira L, Fernandez MT, Santos M, Rocha R, Florêncio MH, Jennings KR (2002) Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36:1199–1208PubMedGoogle Scholar
  132. Moon HS, Lee HG, Choi YJ, Kim TG, Cho CS (2007) Proposed mechanisms of (−)-epigallocatechin-3-gallate for anti-obesity. Chem Biol Interact 167:85–89PubMedGoogle Scholar
  133. Munch G, Thome J, Foley P, Schinzel R, Riederer P (2000) Advanced glycation end products in ageing and Alzheimer’s disease. Brain Res Rev 23:134–43Google Scholar
  134. Murase T, Misawa K, Haramizu S, Hase T (2009) Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 78:78–84PubMedGoogle Scholar
  135. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Acosta JH, Patel JM, Johnson RJ (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol 2006(290):625–631Google Scholar
  136. Okada M, Amamoto T, Tomonaga M, Kawachi A, Yazawa K, Mine K, Fujiwara M (1996) The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience 71:17–25PubMedGoogle Scholar
  137. Ono K, Hasegawa K, Naiki H, Hamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75:742–750PubMedGoogle Scholar
  138. Padiya R, Khatua TN, Bague R, Kuncha M, Banerjee SK (2011) Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats. Nutr Metab (Lond) 8:53Google Scholar
  139. Pan T, Fei J, Zhou X, Jankovic J, Le W (2003) Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury. Life Sci 72:1073–1083PubMedGoogle Scholar
  140. Panickar KS, Polansky MM, Graves DJ, Urban JF Jr, Anderson RA (2012) A procyanidin type A trimer from cinnamon extract attenuates glial cell swelling and the reduction in glutamate uptake following ischemia-like injury in vitro. Neuroscience 202:87–98PubMedGoogle Scholar
  141. Papaioannou N, Tooten PC, van Ederen AM, Bohl JR, Rofina J, Tsangaris T, Gruys E (2001) Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 8:11–21PubMedGoogle Scholar
  142. Park CE, Kim MJ, Lee JH, Min BI, Bae H, Choe W, Kim SS, Ha J (2007) Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp Mol Med 39:222–229PubMedGoogle Scholar
  143. Patel J, Iyer A, Brown L (2009) Evaluation of the chronic complications of diabetes in a high fructose diet in rats. Ind J Biochem Biophys 46:66–72Google Scholar
  144. Peterson DW, George RC, Scaramozzino F, LaPointe NE, Anderson RA, Graves DJ, Lew J (2009) Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro. J Alzheimers Dis 17:585–597PubMedGoogle Scholar
  145. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292:E1378–E1387PubMedGoogle Scholar
  146. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y (2004) Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res 36:119–125PubMedGoogle Scholar
  147. Qin B, Polansky MM, Anderson RA (2009) Cinnamon extract regulates plasma levels of adipose-derived factors and expression of multiple genes related to carbohydrate metabolism and lipogenesis in adipose tissue of fructose-fed rats. Horm Metab Res 42:187–193PubMedGoogle Scholar
  148. Qin B, Panickar KS, Anderson RA (2010) Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol 4:685–693PubMedGoogle Scholar
  149. Rahman K, Lowe GM (2006) Garlic and cardiovascular disease: a critical review. J Nutr 136:736S–740SPubMedGoogle Scholar
  150. Ramassamy C, Christen Y, Clostre F, Costentin J (1992) The Ginkgo biloba extract, EGb 761®, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies. J Pharm Pharmacol 44:943–945PubMedGoogle Scholar
  151. Ray B, Chauhan NB, Lahiri DK (2011a) The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD). Curr Med Chem 18:3306–3313PubMedGoogle Scholar
  152. Ray B, Chauhan NB, Lahiri DK (2011b) Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model. J Neurochem 117:388–402PubMedGoogle Scholar
  153. Reisin E (2009) The benefit of the Mediterranean-style diet in patients with newly diagnosed diabetes. Curr Hypertens Rep 12:56–8Google Scholar
  154. Ren J, Fan C, Chen N, Huang J, Yang Q (2011) Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 36:2352–2362Google Scholar
  155. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214:177–187PubMedGoogle Scholar
  156. Riviere C, Richard T, Quentin L, Krisa S, Merillon JM, Monti JP (2007) Inhibitory activity of stilbenes on Alzheimer’s beta-amyloid fibrils in vitro. Bioorg Med Chem 15:1160–1167PubMedGoogle Scholar
  157. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND (2006) Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 55:928–934PubMedGoogle Scholar
  158. Rojas P, Serrano-García N, Medina-Campos ON, Pedraza-Chaverri J, Maldonado PD, Ruiz-Sánchez E (2011) S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice. J Nutr Biochem 22:937–944PubMedGoogle Scholar
  159. Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA (2009) Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr 28:16–21PubMedGoogle Scholar
  160. Ruan H, Yang Y, Zhu X, Wang X, Chen R (2009) Neuroprotective effects of (+/−)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice. Neurosci Lett 450:152–157PubMedGoogle Scholar
  161. Saiko P, Szakmary A, Jaeger W, Szekeres T (2008) Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 658:68–94PubMedGoogle Scholar
  162. Saleem S, Ahmad M, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Islam F (2006) Behavioral and histologic neuroprotection of aqueous garlic extract after reversible focal cerebral ischemia. J Med Food 9:537–544PubMedGoogle Scholar
  163. Sanmukhani J, Anovadiya A, Tripathi CB (2011) Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: an acute and chronic study. Acta Pol Pharm 68:769–775PubMedGoogle Scholar
  164. Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y, Takeuchi M, Makita Z (2001) Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease. Brain Res 888:256–262PubMedGoogle Scholar
  165. Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, Muller-Spahn F (2003) Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 49:380–383PubMedGoogle Scholar
  166. Scapagnini G, Sonya V, Nader AG, Calogero C, Zella D, Fabio G (2011) Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44:192–201PubMedGoogle Scholar
  167. Schafer DP, Lehrman EK, Stevens B (2012) The “quad-partite” synapse: Microglia–synapse interactions in the developing and mature CNS. Glia 61:24–36PubMedGoogle Scholar
  168. Scholl J (2012) Traditional dietary recommendations for the prevention of cardiovascular disease: do they meet the needs of our patients? Cholesterol 2012:367898Google Scholar
  169. Scott BL, Bazan NG (1989) Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci USA 86:2903–2907PubMedGoogle Scholar
  170. Sharma S, Zhuang Y, Ying Z, Wu A, Gomez-Pinilla F (2009) Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma. Neuroscience 161:1037–1044PubMedGoogle Scholar
  171. Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ (2008) Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res 2008:581348PubMedGoogle Scholar
  172. Shenouda SM, Vita JA (2007) Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr 26:366S–372SPubMedGoogle Scholar
  173. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64:353–356PubMedGoogle Scholar
  174. Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C (2008) Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem 56:4855–4873PubMedGoogle Scholar
  175. Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR (1999) Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging 20:395–405PubMedGoogle Scholar
  176. Sohal RS, Agarwal S, Candas M, Forster MJ, Lal H (1994) Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech Ageing Dev 76:215–224PubMedGoogle Scholar
  177. Son TG, Camandola S, Mattson MP (2008) Hormetic dietary phytochemicals. Neuromolecular Med 10:236–246PubMedGoogle Scholar
  178. Sönmez Ü, Sönmez A, Erbil G, Tekmen I, Baykara B (2007) Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett 420:133–137PubMedGoogle Scholar
  179. Spencer JP (2009) The impact of flavonoids on memory: physiological and molecular considerations. Chem Soc Rev 38:1152–1161PubMedGoogle Scholar
  180. Storz P (2011) Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid Redox Signal 14:593–605PubMedGoogle Scholar
  181. Su HM, Bernardo L, Mirmiran M, Ma XH, Corso TN, Nathanielsz PW, Brenna JT (1999a) Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. Pediatr Res 45:87–93PubMedGoogle Scholar
  182. Su HM, Bernardo L, Mirmiran M, Ma XH, Nathanielsz PW, Brenna JT (1999b) Dietary 18:3n-3 and 22:6n-3 as sources of 22:6n-3 accretion in neonatal baboon brain and associated organs. Lipids 34(Suppl):S347–S350PubMedGoogle Scholar
  183. Takeuchi M, Bucala R, Suzuki T, Ohkubo T, Yamazaki M, Koike T, Kameda Y, Makita Z (2000) Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J Neuropathol Exp Neurol 59:1094–1105PubMedGoogle Scholar
  184. Tamura Y, Ogihara T, Uchida T, Ikeda F, Kumashiro N, Nomiyama T, Sato F, Hirose T, Tanaka Y, Mochizuki H, Kawamori R, Watada H (2007) Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappa B in db/db mice. Diabetologia 50:131–141PubMedGoogle Scholar
  185. Tattelman E (2005) Health effects of garlic. Am Fam Physician 72:103–106PubMedGoogle Scholar
  186. Taubes G (2008) Good calories. Fats, Carbs, and the Controversial Science of Diet and Health, AA Knopf, New York, Bad CaloriesGoogle Scholar
  187. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673–4676PubMedGoogle Scholar
  188. van der Heide LP, Smidt MP (2005) Regulation of FoxO activity by CBP/p300-mediated acetylation. Trends Biochem Sci 30:81–86PubMedGoogle Scholar
  189. van der Horst A, Burgering BM (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8:440–450PubMedGoogle Scholar
  190. Velayutham P, Babu A, Liu D (2008) Green tea catechins and cardiovascular health: an update. Curr Med Chem 15:1840–1850Google Scholar
  191. Vicente Miranda H, Outeiro TF (2010) The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 221:13–25PubMedGoogle Scholar
  192. Vignes M, Maurice T, Lanté F, Nediar M, Thethi K, Guiramand J, Recasens M (2006) Anxiolytic properties of green tea polyphenol (−)-epigallocatechin gallate (EGCG). Brain Res 1110:102–115PubMedGoogle Scholar
  193. Vlassara H, Fuh H, Donnelly T, Cybulsky M (1995) Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1:447–456PubMedGoogle Scholar
  194. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY (2002) Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958:439–447PubMedGoogle Scholar
  195. Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM (2006) Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 20:2313–2320PubMedGoogle Scholar
  196. Wang JG, Anderson RA, Graham GM, Chu MC, Sauer MV, Guarnaccia MM, Lobo RA (2007) The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril 88:240–243PubMedGoogle Scholar
  197. Wang R, Li YB, Li YH, Xu Y, Wu HL, Li XJ (2008) Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res 1210:84–91PubMedGoogle Scholar
  198. Ward RE, Huang W, Curran OE, Priestly JV, Michael-Titus AT (2010) Docosahexaenoic acid prevents white matter damage following spinal cord injury. J Neurotrauma 27:1–12Google Scholar
  199. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM (1996) Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97:238–243PubMedGoogle Scholar
  200. Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE, Shore AC (2010) Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia 53:1722–1726PubMedGoogle Scholar
  201. Willett WC (2006) The Mediterranean diet: science and practice. Public Health Nutr 9:105–110PubMedGoogle Scholar
  202. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, Weber P (2006) Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136:2512–2518PubMedGoogle Scholar
  203. Wu A, Molteni R, Ying Z, Gomez-Pinilla F (2003) A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience 119:365–375PubMedGoogle Scholar
  204. Wu A, Ying Z, Gomez-Pinilla F (2004) Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21:1457–1467PubMedGoogle Scholar
  205. Wu A, Ying Z, Gomez-Pinilla F (2005) Omega-3 fatty acids supplementation restores homeostatic mechanisms disrupted by traumatic brain injury. J Neurotrauma 22:1212Google Scholar
  206. Wu A, Ying Z, Gomez-Pinilla F (2006) Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol 197:309–317PubMedGoogle Scholar
  207. Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T (2011). Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease. Neurosignals 19:163–174Google Scholar
  208. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005) The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518:40–46PubMedGoogle Scholar
  209. Yan SD, Stern D, Kane MD, Kuo YM, Lampert HC, Roher AE (1998) RAGE-Aβ interactions in the pathophysiology of Alzheimer’s disease. Restor Neurol Neurosci 12:167–173PubMedGoogle Scholar
  210. Yao D, Brownlee M (2010) Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59:249–55PubMedGoogle Scholar
  211. Yoshitake T, Yoshitake S, Kehr J (2010) The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 159:659–668PubMedGoogle Scholar
  212. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, Islam F (2009) Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 1250:242–253PubMedGoogle Scholar
  213. Zhao J, Yu S, Zheng W, Feng G, Luo G, Wang L, Zhao Y (2010) Curcumin improves outcomes and attenuates focal cerebral ischemic injury via anti-apoptotic mechanisms in rats. Neurochem Res 35:374–379PubMedGoogle Scholar
  214. Zhong L, Furne JK, Levitt MD (2006) An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers. Am J Clin Nutr 84:551–555PubMedGoogle Scholar
  215. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA (2006) Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 3:45–53PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Akhlaq A. Farooqui
    • 1
  1. 1.Ohio State UniversityColumbusUSA

Personalised recommendations